Deepak Nitrite (DEEPAKNTR) Q1 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 25/26 earnings summary
23 Nov, 2025Executive summary
Q1 FY26 saw resilient operational performance despite global headwinds, with steady volumes and improved product mix in phenolics, but challenges in agrochemical intermediates due to slow recovery and Chinese oversupply.
Q1 FY26 total income was ₹1,897 crore, down 13% year-over-year and 7% sequentially; EBITDA at ₹197 crore, down 40% year-over-year but up 11% sequentially.
Strategic focus on import substitution, integration, capacity expansion, process optimization, and sustainability initiatives underpinned business resilience and future growth prospects.
Expansion into new applications and geographies, along with new product launches, is expected to drive incremental annualized revenue, with commercial volumes ramping up from January 2026.
Standalone and consolidated unaudited financial results for the quarter ended June 30, 2025, were approved by the board on August 13, 2025.
Financial highlights
Consolidated Q1 FY26 revenue was ₹1,897 crore, down 7% sequentially and 13% year-over-year; consolidated EBITDA rose 11% sequentially to ₹197 crore, with margins expanding by 100 bps to 10%.
Q1 FY26 PAT was ₹112 crore, down 45% year-over-year and sequentially; EPS stood at ₹8.23, a 45% decline year-over-year.
Standalone revenue was ₹612.28 crore, down from ₹619.70 crore in the previous quarter and ₹654.47 crore in the same quarter last year; standalone net profit was ₹30.29 crore.
Government incentives excluded: ₹17 crore in Q1 and ₹161 crore in Q4 FY25.
Basic & diluted EPS (consolidated) was ₹8.23, down from ₹14.84 in the previous quarter and ₹14.85 year-over-year.
Outlook and guidance
Anticipates demand rebound in agro intermediates and continued steady demand in non-agro applications.
Key projects, including new plants and backward integration, are expected to enhance supply security, cost optimization, and profitability from Q3 FY26 onwards.
CapEx plans remain on track, with ₹10,000 crore investment over three years and no slowdown expected due to global trade uncertainties.
Strategic investments in backward and forward integration, renewable energy, and R&D to drive growth.
Financial results were reviewed and recommended by the audit committee and approved by the board on August 13, 2025.
Latest events from Deepak Nitrite
- Q3 FY26 saw 3% revenue growth, higher EBITDA, and margin resilience amid global headwinds.DEEPAKNTR
Q3 25/2613 Feb 2026 - Q1 FY25 revenue and profit surged on strong phenolics and expansion progress.DEEPAKNTR
Q1 20252 Feb 2026 - H1 FY25 revenue and profit rose on phenolics strength and major polycarbonate investment.DEEPAKNTR
Q2 202514 Jan 2026 - Q3 FY25 profit and revenue fell, but margin recovery is expected as new projects ramp up.DEEPAKNTR
Q3 202516 Dec 2025 - FY25 revenue up 8% YoY; Q4 recovery and expansions set stage for growth in FY26.DEEPAKNTR
Q4 24/2520 Nov 2025 - Sequential margin gains and project commissioning set the stage for growth despite tariff headwinds.DEEPAKNTR
Q2 202614 Nov 2025